Aquinox Pharmaceuticals Inc (NASDAQ:AQXP)

14.62
Delayed Data
As of Feb 16
 -1.69 / -10.36%
Today’s Change
10.02
Today|||52-Week Range
19.35
+24.32%
Year-to-Date
No recent news for Aquinox Pharmaceuticals Inc.

Today’s Trading

Previous close16.31
Today’s open16.36
Day’s range14.46 - 16.77
Volume198,865
Average volume (3 months)105,054
Market cap$343.1M
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-13.29%
Earnings growth (this year)-1.79%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.37

Competitors

 Today’s
change
Today’s
% change
CNCEConcert Pharmaceutic...-0.03-0.14%
RARXRa Pharmaceuticals I...+0.04+0.59%
CRVSCorvus Pharmaceutica...-0.08-0.98%
CCXIChemoCentryx Inc+0.07+0.74%
Data as of 4:00pm ET, 02/16/2018

Financials

Next reporting dateMarch 19, 2018
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$0.00
Annual profit (last year)-$37.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
David J. Main
Chief Operating Officer
Lloyd Mackenzie
Corporate headquarters
Vancouver, British Columbia

Forecasts